Search

Author/Creator Weitz, I. C.

1. P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396). (23rd June 2022)

Authors:
Röth, A.; Barcellini, W.; D'Sa, S.; Miyakawa, Y.; Broome, C. M.; Michel, M.; Kuter, D. J.; Jilma, B.; Tvedt, T. H. A.; Weitz, I. C.; Sourdille, T.; Wang, J.; Vagge, D. S.; Kralova, K.; Shafer, F.; Wardecki, M.; Lee, M.; Berentsen, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY. (23rd June 2022)

Authors:
Röth, A.; Barcellini, W.; D'Sa, S.; Miyakawa, Y.; Broome, C. M.; Michel, M.; Kuter, D. J.; Jilma, B.; Tvedt, T. H. A.; Weitz, I. C.; Sourdille, T.; Wang, J.; Vagge, D. S.; Kralova, K.; Shafer, F.; Wardecki, M.; Lee, M.; Berentsen, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S304: SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2 YEAR FOLLOW-UP FROM THE CARDINAL STUDY. (23rd June 2022)

Authors:
Röth, A.; Broome, C. M.; Barcellini, W.; Henrik Anderson Tvedt, T.; Miyakawa, Y.; D'Sa, S.; Cella, D.; Joly, F.; Wang, J.; Sourdille, T.; Shafer, F.; Wardęcki, M.; Weitz, I. C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
205
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search